Our interdisciplinary and multi-institutional team is composed of researchers, clinicians, and citizens with complementary expertise and experiences in palliative and end-of-life care, epidemiology, public health, psychology, addiction, bioethics, law, psychedelic therapies, psychiatry, and nursing. All share a commitment to improving health care through research and knowledge transfer activities.
Researchers
Michel Dorval, Ph.D.
• Full Professor, Faculty of Pharmacy, Université Laval
• CHU de Québec-Université Laval Research Centre, Oncology Division
• Research Center of CISSS of Chaudière-Appalaches
• Réseau Québécois de Recherche en Soins Palliatifs et de Fin de Vie (RQSPAL)
Jean-Sébastien Fallu, Ph.D.
• Associate Professor, School of Psychoeducation, Université de Montreal
• Center for Public Health Research (CReSP)
• Institut Universitaire sur les Dépendances
• Recherche et Interventions sur les Substances Psychoactives - Quebec (RISQ)
Yann Joly, Ph.D. (DCL), FCAHS, Ad.E.
• Full Professor, Faculty of Medicine and Health Sciences, McGill University
• Director, Centre for Genomics and Policy (CGP) Human Ethics, McGill University
Houman Farzin, MD, M.Sc, CCFP
• Family and Palliative Care Physician, Jewish General Hospital
• Lecturer, Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University
Pierre Gagnon, MD, FRCPC
• Full Professor, Department of Psychiatry and Neuroscience, Faculty of Medicine, Université Laval
• CHU de Québec-Université Laval Research Centre, Oncology Division
• Director, Réseau Québécois de Recherche en Soins Palliatifs et de Fin de Vie (RQSPAL)
Johanne Hébert, inf., Ph.D.
• Full Professor, Department of Health Sciences, UQAR
• Research Center of CISSS of Chaudière-Appalaches
• Réseau Québécois de Recherche en Soins Palliatifs et de Fin de Vie (RQSPAL)
• Réseau de recherche sur les interventions infirmières du Québec (RRISIQ)
Collaborators
Sue-Ling Chang, MPH, M.Sc.
• CHU de Québec-Université Laval Research Centre, Oncology Division Centre de Recherche sur le Cancer, Université Laval
Pierre Deschamps, C.M., Ad. E.
• Member of the Quebec Bar
• Member of the End-of-Life Care Commission
Robert Foxman
• Robert, a cancer survivor and recipient of a Health Canada Section 56 exemption allowing for legal possession and use of psilocybin for a one-year period, has undergone two psychedelic-assisted therapy sessions.
Jean-François Stephan, MD.
Diane Tapp, inf., Ph.D.
• Associate Professor, Faculty of Nursing, Université Laval
• Director, Institut de Soins Palliatifs et de Fin de Vie Michel-Sarrazin – Université Laval
• Co-Director, Réseau Québécois de Recherche en Soins Palliatifs et de Fin de Vie (RQSPAL)
Florence Moureaux
• After a recurrence of metastatic cancer in February 2021, Florence underwent three sessions of psilocybin-assisted therapy, made possible, initially, through an exemption under Section 56, and later through Health Canada's Special Access Program.
Olivia Nguyen
MD, MM, CCMF(SP), FCMF, FRCPC
• Palliative care physician, CIUSSS NIM
• Assistant clinical professor, Faculty of Medecine, Université de Montréal
• President of the Société québécoise des médecins de soins palliatifs (SQMDSP)
Marion Barrault-Couchouron, PhD
• Psychologist-psychotherapist, Bergonié Institute, Bordeaux
• Researcher, INSERM U1219, Université de Bordeaux
Nicolas Garel
• Psychiatrist, Psychiatry Department, CHUM
• Clinical Assistant Professor, Department of Psychiatry and Addictology, Université de Montréal
• Regular Researcher, CHUM Research Center
Students
Louis Plourde, M.Sc.
• Faculty of Pharmacy, Université Laval
• CHU de Québec-Université Laval Research Centre, Oncology Division
• Centre de Recherche sur le Cancer, Université Laval
• Réseau Québécois de Recherche en Soins Palliatifs et de Fin de Vie (RQSPAL)
Marianne Masse-Grenier, B.Sc.
• Faculty of Pharmacy, Université Laval
• CHU de Québec-Université Laval Research Centre, Oncology Division
• Centre de Recherche sur le Cancer, Université Laval
• Réseau Québécois de Recherche en Soins Palliatifs et de Fin de Vie (RQSPAL)
Ariane Bélanger, inf. B.Sc.
• Faculty of Pharmacy, Université Laval
• CHU de Québec-Université Laval Research Centre, Oncology Division
• Réseau Québécois de Recherche en Soins Palliatifs et de Fin de Vie (RQSPAL)
• Clinical Nurse, Quebec University Institute of Cardiology and Pulmonology
François Provost, B.Sc.
• Faculty of Social Sciences, Université Laval
• CHU de Québec-Université Laval Research Centre, Oncology Division
Gabriel Bélanger
• Faculty of Pharmacy, Université Laval
• CHU de Québec-Université Laval Research Centre, Oncology Division
Diana Rekkam
• Faculty of Pharmacie, Université Laval
• CHU de Québec-Université Laval Research Centre, Oncology Division
Are you interested in seeing the contribution of our team in the media?
